Terms ending in 2041
Every in-force patent on Sanofi's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,898,175 | Treatment of Abnormal Bone Conditions in Acid Sphingomyelinase Deficiency Patients In force · High confidence | Genzyme Corporation | In force | High confidence | |
| US 12,115,128 | Closure for Medicament Container In force · High confidence | Sanofi | In force | High confidence | |
| US 11,872,381 | Drive Train for Dial of a Torsion-Spring Assisted Wind-Up Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,667,672 | Dosage Measurement System In force · High confidence | Sanofi | In force | High confidence | |
| US 12,230,063 | An Eye-Tracking Device and Method In force · High confidence | Sanofi | In force | High confidence | |
| US 11,970,690 | Methods of Cultivating Bordetella Species In force · High confidence | Sanofi Pasteur Inc. | In force | High confidence | |
| US 12,171,990 | A Sensor Device for Attachment to an Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,123,873 | Lateral Flow Immunoassay Strip Device In force · High confidence | Sanofi | In force | High confidence | |
| US 11,878,146 | Measurement Probe for an Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 11,967,407 | Method of Adjusting Medication Doses In force · High confidence | Sanofi | In force | High confidence | |
| 56 more term ends in 2041 · Pro | |||||
10 of 66 patents shown. Soonest term end first, then patent number.
Pro members see all 66.
59 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.